Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 2, 1999, Pages 119-122

  Lundqvist, Anders ^a,b   Tolfvenstam, Thomas ^b   Brytting, Maria ^c   Stolt, Carl Magnus ^a   Hedman, Klaus ^d   Broliden, Kristina ^b,c  

^a BORÅS HOSPITAL   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; BONE MARROW; ERYTHEMA INFECTIOSUM; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; SEROPREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, VIRAL; BONE MARROW; CAPSID; CAPSID PROTEINS; DNA, VIRAL; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0032840007     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655499750006128     Document Type: Article

References (31)

1. Anderson LJ, Young NS, editors. Monographs in virology: human parvovirus B19. Vol. 20, 1997, Karger, Basel.
2. Saunders PW, Ried MM, Cohen BJ. Human parvovirus induced cytopenias: a report of five cases. Br J Hematol 1986; 63: 407-10.
3. Doran HM, Teall AJ. Neutropenia accompanying erythroid aplasia in human parvovirus infection. Br J Hematol 1988; 69: 287-8.
4. Nagai K, Morohoshi T, Kudoh T, Yoto Y, Suzuki N, Matsunaga Y. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection. Br J Hematol 1992; 80: 131-2.
5. Inoue S, Kinra NK, Mukkamala SR, Gordon R. Parvovirus B-19 infection: aplastic crisis, erythema infectiosum and idiopathic thrombocytopenic purpura. Pediatr Infect Dis J 1991; 10: 251-3.
6. Potter CG, Potter AC, Hatton CS, Chapel HM, Anderson MJ, Pattson JR, et al. Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). J Clin Invest 1987; 79: 1486-92.
7. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 Parvovirus. Science 1993; 262: 114-7.
8. Liu W, Ittmann M, Liu J, et al. Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry. Hum Pathol. 1997; 28: 760-6.
9. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53: 229-32.
10. Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993; 167: 744-8.
11. Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K. Epitope-type specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 1995; 172: 1431-6.
12. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol. 1993; 4: 123-9.
13. Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurements of IgG avidity. J Infect Dis 1995; 171: 710-3.
14. Broliden K, Tolfvenstam T, Ohlsson S, Henter. JI. Persistent B19 Parvovirus infection in pediatric malignancies. Med Ped Oncol 1998; 31: 66-72.
15. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287-94.
16. Kurtzman GJ, Cohen B, Meyers P, Amunullah A, Young NS. Persistent B19 Parvovirus infection as a cause of severe chronic anemia in children with acute lymphocytic leukemia. Lancet 1988; 2: 1159-62.
17. Graeve JLA, de Alarcon PA, Naides SJ. Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol 1989; 11: 441-4.
18. Weiland HT, Salimans MM, Fibbe WE, Kluin PM, Cohen BJ. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant patient. Br J Haematol 1989; 71: 300.
19. Frickhofen N, Abkowitz JL, Safford M, Berry JM, Antunez-deMayolo J, Astrow A, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926-33.
20. Pont J, Puchhammer-Stöckl E, Chott A, Popow-Kraupp T, Kienzer H, Postner G, et al. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Hematol 1992; 80: 160-5.
21. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin. N Engl J Med 1989; 321: 519-23.
22. Baurmann H, Schwarz TF, Oertel J, Serke S, Roggendorf M, Huhn D. Acute parvovirus B19 infection mimicking myelodys-plastic syndrome of the bone marrow. Ann Hematol 1992; 64: 43.
23. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattison JR, Tyrrell DA. Experimental parvoviral infection in humans. J Infect Dis 1985; 152: 257-65.
24. Gahr M, Pekrun A, Eiffert H. Persistence of parvovirus B19-DNA in blood of a child with severe combined immunodeficiency associated with chronic pure red cell aplasia. Eur J Ped 1991; 150: 470-2.
25. Faden H, Gary GW, Anderson LJ. Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Inf Dis 1992; 15: 595-7.
26. Söderlund M, Ruutu P, Ruutu T, Asikainen K, Franssila R, Hedman K. Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand J Infect Dis 1997; 29: 129-35.
27. Sasaki T, Murai C, Muryoi T, Takahashi Y, Munakata Y, Sugamura K, Abe K. Persistent infection of human parvovirus B19 in a normal subject. Lancet 1995; 346: 851.
28. Lundqvist A, Tolfvenstam T, Söderlund M, Broliden K. Clinical and laboratory findings in patients with persistent Parvovirus B19 DNA in bone marrow. Scand J Inf Dis 1999; 31: 11-6.
29. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063-5.
30. Nikkari S, Lappalainen H, Saario R, Lammintausta K, Kotilainen P. Detection of Parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis. Eur J Clin Microbiol Infect Dis 1996; 15: 954-7.
31. Erdman DD, Anderson BC, Török TJ, Finkel TH, Anderson LJ. Possible transmission of Parvovirus B19 from intravenous immune globulin. J Med Virol 1997; 53: 233-6.